Antibiotic development - economic, regulatory and societal challenges

Nat Rev Microbiol. 2020 May;18(5):267-274. doi: 10.1038/s41579-019-0293-3. Epub 2019 Nov 19.

¹ Norwegian Institute of Public Health, Oslo, Norway. christine.ardal@fhi.no.
² Global Antibiotic R&D Partnership, Geneva, Switzerland. mbalasegaram@gardp.org.
³ Center for Disease Dynamics, Economics & Policy, Washington, DC, USA. ramanan@cddep.org.
⁴ Fuqua School of Business and Economics Department, Duke University, Durham, NC, USA. mcadams.david@gmail.com.
⁵ Boston University, Boston, MA, USA. mko@bu.edu.
⁶ F2G Ltd, Eccles, UK. john.rex@f2g.com.
⁷ Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand. nithima@fda.moph.go.th.

No abstract available

Publication types